How We Chose
We looked at news from September 15 to October 27, 2026 about companies selling AI products to healthcare organizations and clinicians, and we kept companies with clear evidence of adoption in that window: growth in users, customers, or volume, large deployments, and measured results at specific customers. We ranked them by our editors' judgment of how strong and how recent that evidence is. Funding appears only as context.
Healthcare AI Companies to Watch (November 2026)
| # | Name | Company | Why now |
|---|
| 1 | Vera Health | Clinical evidence search | 800,000+ clinicians; top clinical app download every month since June |
| 2 | Heidi | AI clinical documentation | 2.8M patient visits a week in 190 countries |
| 3 | Healthleap | Inpatient risk detection | Grew from 3 to 50+ hospitals; revenue up more than 10x |
| 4 | Parakeet Health | AI patient access | Recurring revenue up 10x; 6 of the 10 largest dermatology groups |
| 5 | AKASA | Revenue cycle AI | Launched autonomous inpatient coding; volume up almost 6x |
| 6 | DeepScribe | Ambient AI for oncology | Deployed across all 13 Comprehensive Cancer Centers of Nevada sites |
| 7 | Sirona Medical | Cloud radiology software | Usage and recurring revenue up more than 2.5x |
| 8 | Basalt Health | Post-acute admissions AI | Cut referral processing time 86% at Lifepoint |
| 9 | Vitalize | Workforce and capacity AI | St. Luke's cut premium labor spend 54% in 12 weeks |
| 10 | Confido Health | Practice operations AI | 15x growth; one customer doubled collections |
800,000+Clinicians using Vera, up from a few thousand a year earlier
1. Vera Health
Clinical evidence search
- Company
- Vera Health
- Why now
- The most downloaded clinical app every month since June; announced its Series A on October 27, 2026.
Vera Health, founded by MIT graduates Maxime Allouch and Taieb Bennani, searches more than 60 million papers, guidelines, and drug labels and color-codes the strength of the evidence behind each claim in its answers.
Why now
Vera has been the most downloaded clinical app in the world every month since June, and it reaches clinicians in 190 countries, including about 1 in 4 physicians in Spain and Italy, according to its announcement. It now has more daily active users than it had monthly active users when it raised its Series A. Gradient partner Andrew Brackin led its seed round.
Vera Health reviewAndrew Brackin profile
2.8MPatient visits a week supported by Heidi
2. Heidi
AI clinical documentation
- Company
- Heidi
- Why now
- Announced its Series C on September 22, 2026, with annual recurring revenue up from $1 million to $50 million in two years.
Heidi, co-founded by Dr. Tom Kelly, makes an AI scribe and assistant that writes clinical notes from the conversation in the room, in 110 languages. Health systems working with Heidi include NHS Midlands, Health New Zealand, and Beth Israel Lahey Health.
Why now
Heidi supports 2.8 million patient visits a week across 190 countries and has passed 175 million visits in total, according to its announcement. Its annual recurring revenue grew from $1 million to $50 million in two years, and Blackbird, whose partner Michael Tolo backed Heidi at its pre-seed, called it the firm's fastest-growing investment.
Heidi reviewMichael Tolo profile
50+Hospitals using Healthleap, up from three a year earlier
3. Healthleap
Inpatient risk detection
- Company
- Healthleap
- Why now
- Told TechCrunch on October 7, 2026 that it grew from three hospitals to more than 50 in a year.
Siblings Josiah Meyer and Jemima Meyer built Healthleap to read every adult inpatient chart overnight and flag patients who may have undiagnosed malnutrition, delirium, and other conditions.
Why now
Healthleap's revenue grew more than 10 times as its hospital count went from three to more than 50, chief executive Josiah Meyer told TechCrunch. At the Hospital of the University of Pennsylvania, its malnutrition program produced $23.8 million in annualized financial impact from added reimbursement and shorter stays. First Round partner Josh Kopelman co-led its seed round.
Healthleap reviewJosiah Meyer profileJosh Kopelman profile
10xGrowth in annual recurring revenue over the past year
4. Parakeet Health
AI patient access
- Company
- Parakeet Health
- Why now
- Reported 10x growth in annual recurring revenue on October 1, 2026.
Led by co-founder and chief executive Jung Park, Parakeet handles inbound calls, outreach, fax processing, and online scheduling for medical practices, and works with six of the 10 largest dermatology groups in the U.S.
Why now
Parakeet's annual recurring revenue grew 10 times in a year, and it supports more than 2,800 providers at more than 1,100 locations, according to its announcement. The company says it rebooks patients who missed appointments at up to 4.9 times the rate of leading patient-engagement vendors, and it signed a national collaboration with Qualderm Partners, which supports nearly 160 practices.
Parakeet Health reviewJung Park profile
1 in 10U.S. inpatient discharges handled by AKASA's customers
5. AKASA
AI for hospital coding and billing
- Company
- AKASA
- Why now
- Launched autonomous inpatient coding and documentation review on October 2, 2026.
AKASA, led by co-founder and chief executive Malinka Walaliyadde, builds AI that hospital revenue cycle teams use to code patient encounters and review clinical documentation, trained on each health system's own records.
Why now
AKASA's new AI codes an inpatient case less than 90 seconds after discharge, and in blinded third-party evaluations it matched or exceeded human coders on key accuracy measures, according to its announcement. The inpatient volume it processes grew almost six times in a year. Andreessen Horowitz partner Julie Yoo, who led its Series A, called it "frontier AI that can do complex work at scale."
AKASA reviewMalinka Walaliyadde profileJulie Yoo profile
55%Share of U.S. community oncology clinicians using DeepScribe
6. DeepScribe
Ambient AI for oncology
- Company
- DeepScribe
- Why now
- Comprehensive Cancer Centers of Nevada deployed DeepScribe at all 13 locations, announced October 13, 2026.
DeepScribe makes ambient documentation, pre-visit preparation, and coding software built for cancer care, which listens to the visit and drafts the clinical note.
Why now
Comprehensive Cancer Centers of Nevada deployed DeepScribe to all 59 of its oncology clinicians across 13 locations, with more than 90% adoption, according to DeepScribe. The company says it is used by 55% of community oncology clinicians in the U.S., and more practices have signed on.
DeepScribe review
2.7xGrowth in contracted annual recurring revenue in a year
7. Sirona Medical
Cloud radiology software
- Company
- Sirona Medical
- Why now
- Announced its Series D and more than 2.5x growth in usage and recurring revenue on October 15, 2026.
Founded by Cameron Andrews in 2018, Sirona makes RadOS, which puts image storage, viewing, reporting, worklists, and AI for radiologists on one cloud platform.
Why now
Sirona's platform usage and annual recurring revenue grew more than 2.5 times and its contracted recurring revenue 2.7 times year over year, and it is under contract to bring more than 1,000 more radiologists onto RadOS over the next 12 months, according to its announcement. It plans to launch Sirona Global in the UK, the European Union, South Africa, New Zealand, and Australia before the end of 2026.
Sirona Medical reviewCameron Andrews profile
86%Cut in median referral processing time at Lifepoint Health
8. Basalt Health
AI for post-acute admissions
- Company
- Basalt Health
- Why now
- Announced its Lifepoint results and Series A on September 24, 2026.
Ben Hackett, who spent nearly a decade at Accolade, founded Basalt in 2024. Its AI reads referral packets for rehab and skilled nursing admissions and checks them against clinical and payer rules.
Why now
At Lifepoint Health, Basalt cut median referral processing time from 8.5 minutes to 1.2 minutes, and it is rolling out to 111 Lifepoint and ScionHealth markets by the end of 2026, according to its announcement. NEA partner Blake Wu serves on its board.
Basalt Health reviewBen Hackett profileBlake Wu profile
54%Cut in premium labor spend at St. Luke's Health in 12 weeks
9. Vitalize
Workforce and capacity AI
- Company
- Vitalize
- Why now
- Announced its St. Luke's Health results with its Series A on October 6, 2026.
Founded in 2021 by Veeraj Shah and Sanketh Andhavarapu, Vitalize schedules nurses and other staff and matches staffing to bed capacity.
Why now
"In just 12 weeks, we saw a 54% reduction in premium labor spend across overtime and agency costs," David Pereles, chief information officer at St. Luke's Health, said in the announcement. Vitalize manages millions of shifts a week across dozens of health systems.
Vitalize reviewVeeraj Shah profile
15xGrowth since its previous funding round
10. Confido Health
AI agents for practice operations
- Company
- Confido Health
- Why now
- Reported 15x growth with its Series A extension on October 14, 2026.
Confido's AI agents answer and place patient calls and handle scheduling, insurance checks, referrals, refills, and payments. It sells to private equity firms first and then to the specialty practices they own.
Why now
Confido has grown 15 times since its last round, and its AI reached handle rates above 95% in core front-office tasks, according to its announcement. "We have doubled collections in our payments department since deploying Confido," said Michael Pascetta, chief financial officer at Vision Innovation Partners.
Confido Health review
What to Watch Next Month
- Vera's partnerships. Vera Health plans deeper partnerships with medical societies, publishers, and health systems, building on its integration of American College of Emergency Physicians guidelines.
- Sirona Global. Sirona Medical plans to launch its international program in the UK, the European Union, and other markets before the end of 2026.
- Heidi beyond notes. Heidi is moving from writing notes to AI that handles the clinical work that follows a visit, and into France and Germany.
The Healthcare AI Companies to Watch list is updated monthly. This is the first edition. Past editions will be linked here, and every HIR list and report is in our research library.
